These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 12727822

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prostate secretory protein of 94 amino acids (PSP-94) and its peptide (PCK3145) as potential therapeutic modalities for prostate cancer.
    Shukeir N, Garde S, Wu JJ, Panchal C, Rabbani SA.
    Anticancer Drugs; 2005 Nov; 16(10):1045-51. PubMed ID: 16222145
    [Abstract] [Full Text] [Related]

  • 4. Effect of nucleoside analogue BCH-4556 on prostate cancer growth and metastases in vitro and in vivo.
    Rabbani SA, Harakidas P, Bowlin T, Attardo G.
    Cancer Res; 1998 Aug 01; 58(15):3461-5. PubMed ID: 9699681
    [Abstract] [Full Text] [Related]

  • 5. Parathyroid hormone-related protein as a growth regulator of prostate carcinoma.
    Dougherty KM, Blomme EA, Koh AJ, Henderson JE, Pienta KJ, Rosol TJ, McCauley LK.
    Cancer Res; 1999 Dec 01; 59(23):6015-22. PubMed ID: 10606251
    [Abstract] [Full Text] [Related]

  • 6. Induction of parathyroid hormone-related peptide by the Ras oncogene: role of Ras farnesylation inhibitors as potential therapeutic agents for hypercalcemia of malignancy.
    Aklilu F, Park M, Goltzman D, Rabbani SA.
    Cancer Res; 1997 Oct 15; 57(20):4517-22. PubMed ID: 9377563
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Over-production of parathyroid hormone-related peptide results in increased osteolytic skeletal metastasis by prostate cancer cells in vivo.
    Rabbani SA, Gladu J, Harakidas P, Jamison B, Goltzman D.
    Int J Cancer; 1999 Jan 18; 80(2):257-64. PubMed ID: 9935208
    [Abstract] [Full Text] [Related]

  • 9. Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo.
    Achbarou A, Kaiser S, Tremblay G, Ste-Marie LG, Brodt P, Goltzman D, Rabbani SA.
    Cancer Res; 1994 May 01; 54(9):2372-7. PubMed ID: 8162583
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
    Lokeshwar BL, Schwartz GG, Selzer MG, Burnstein KL, Zhuang SH, Block NL, Binderup L.
    Cancer Epidemiol Biomarkers Prev; 1999 Mar 01; 8(3):241-8. PubMed ID: 10090302
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of parathyroid hormone-related protein causes hypercalcemia but not bone metastases in a murine model of mammary tumorigenesis.
    Wysolmerski JJ, Dann PR, Zelazny E, Dunbar ME, Insogna KL, Guise TA, Perkins AS.
    J Bone Miner Res; 2002 Jul 01; 17(7):1164-70. PubMed ID: 12096830
    [Abstract] [Full Text] [Related]

  • 12. Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude mice bearing transplanted human PTHrP-producing tumors.
    Sato K, Yamakawa Y, Shizume K, Satoh T, Nohtomi K, Demura H, Akatsu T, Nagata N, Kasahara T, Ohkawa H.
    J Bone Miner Res; 1993 Jul 01; 8(7):849-60. PubMed ID: 8352067
    [Abstract] [Full Text] [Related]

  • 13. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
    Uy HL, Mundy GR, Boyce BF, Story BM, Dunstan CR, Yin JJ, Roodman GD, Guise TA.
    Cancer Res; 1997 Aug 01; 57(15):3194-9. PubMed ID: 9242449
    [Abstract] [Full Text] [Related]

  • 14. Parathyroid hormone-related protein induces interleukin 8 production by prostate cancer cells via a novel intracrine mechanism not mediated by its classical nuclear localization sequence.
    Gujral A, Burton DW, Terkeltaub R, Deftos LJ.
    Cancer Res; 2001 Mar 01; 61(5):2282-8. PubMed ID: 11280799
    [Abstract] [Full Text] [Related]

  • 15. Direct evidence that PTHrP expression promotes prostate cancer progression in bone.
    Deftos LJ, Barken I, Burton DW, Hoffman RM, Geller J.
    Biochem Biophys Res Commun; 2005 Feb 11; 327(2):468-72. PubMed ID: 15629138
    [Abstract] [Full Text] [Related]

  • 16. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E, Azuma Y, Saito H, Tsunenari T, Watanabe T, Hirabayashi M, Sato K, Yamada-Okabe H, Ogata E.
    Clin Cancer Res; 2005 Jun 01; 11(11):4198-203. PubMed ID: 15930357
    [Abstract] [Full Text] [Related]

  • 17. Effects of passive immunization against parathyroid hormone-related protein: PTHrP is the responsible factor in mediating hypercalcemia in the Walker carcinosarcoma 256 rat model.
    Schilling T, Blind E, Baier R, Sinn HP, Moallem E, Silver J, Ziegler R, Raue F.
    J Bone Miner Res; 1995 Jan 01; 10(1):7-16. PubMed ID: 7747633
    [Abstract] [Full Text] [Related]

  • 18. Androgen regulation of parathyroid hormone-related peptide production in human prostate cancer cells.
    Pizzi H, Gladu J, Carpio L, Miao D, Goltzman D, Rabbani SA.
    Endocrinology; 2003 Mar 01; 144(3):858-67. PubMed ID: 12586762
    [Abstract] [Full Text] [Related]

  • 19. Urokinase receptor antibody can reduce tumor volume and detect the presence of occult tumor metastases in vivo.
    Rabbani SA, Gladu J.
    Cancer Res; 2002 Apr 15; 62(8):2390-7. PubMed ID: 11956102
    [Abstract] [Full Text] [Related]

  • 20. [PTHrP and breast cancer].
    Devys A, Lortholary A, Audran M.
    Bull Cancer; 2001 Nov 15; 88(11):1075-80. PubMed ID: 11741801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.